These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31569935)

  • 1. Immunophenotypic features of leukemic stem cells and bulk of blasts in acute myeloid leukemia.
    Ivanivska TS; Sklyarenko LM; Zavelevich MP; Philchenkov AA; Koval SV; Polishchuk AS; Gluzman DF
    Exp Oncol; 2019 Sep; 41(3):207-209. PubMed ID: 31569935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRP1 protein expression in leukemic stem cells as a negative prognostic marker in acute myeloid leukemia patients.
    Paprocka M; Bielawska-Pohl A; Rossowska J; Krawczenko A; Duś D; Kiełbiński M; Haus O; Podolak-Dawidziak M; Kuliczkowski K
    Eur J Haematol; 2017 Nov; 99(5):415-422. PubMed ID: 28805931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.
    Daga S; Rosenberger A; Quehenberger F; Krisper N; Prietl B; Reinisch A; Zebisch A; Sill H; Wölfler A
    Cancer Med; 2019 Apr; 8(4):1771-1778. PubMed ID: 30848055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
    Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
    BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia.
    Zeijlemaker W; Kelder A; Cloos J; Schuurhuis GJ
    Curr Protoc Cytom; 2019 Dec; 91(1):e66. PubMed ID: 31763792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A; Gillis D; Lewis I
    J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic characterization of leukemic stem cells in acute myeloid leukemia using single tube 10-colour panel by multiparametric flow cytometry: Deciphering the spectrum, complexity and immunophenotypic heterogeneity.
    Das N; Panda D; Gajendra S; Gupta R; Thakral D; Kaur G; Khan A; Singh VK; Vemprala A; Bakhshi S; Seth R; Sahoo RK; Sharma A; Rai S; Prajapati VK; Singh S
    Int J Lab Hematol; 2024 Aug; 46(4):646-656. PubMed ID: 38456256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD117/CD34 expression in leukemic blasts.
    Wells SJ; Bray RA; Stempora LL; Farhi DC
    Am J Clin Pathol; 1996 Aug; 106(2):192-5. PubMed ID: 8712172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
    Marchand T; Pinho S
    Front Immunol; 2021; 12():775128. PubMed ID: 34721441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen expression on a putative leukemic stem cell population and AML blast.
    Garg S; Ghosh K; Madkaikar M
    Int J Hematol; 2016 May; 103(5):567-71. PubMed ID: 26910244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemic stem cell signatures in Acute myeloid leukemia- targeting the Guardians with novel approaches.
    Thakral D; Gupta R; Khan A
    Stem Cell Rev Rep; 2022 Jun; 18(5):1756-1773. PubMed ID: 35412219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
    Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
    Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotyping by Multiparameter Flow Cytometry.
    Chen W; Luu HS
    Methods Mol Biol; 2017; 1633():51-73. PubMed ID: 28735480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells.
    Kornblau SM; Qutub A; Yao H; York H; Qiu YH; Graber D; Ravandi F; Cortes J; Andreeff M; Zhang N; Coombes KR
    PLoS One; 2013; 8(10):e78453. PubMed ID: 24223100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML.
    Haubner S; Perna F; Köhnke T; Schmidt C; Berman S; Augsberger C; Schnorfeil FM; Krupka C; Lichtenegger FS; Liu X; Kerbs P; Schneider S; Metzeler KH; Spiekermann K; Hiddemann W; Greif PA; Herold T; Sadelain M; Subklewe M
    Leukemia; 2019 Jan; 33(1):64-74. PubMed ID: 29946192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow Cytometric Identification of Hematopoietic and Leukemic Blast Cells for Tailored Clinical Follow-Up of Acute Myeloid Leukemia.
    Weeda V; Mestrum SGC; Leers MPG
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia.
    Cloos J; Harris JR; Janssen JJWM; Kelder A; Huang F; Sijm G; Vonk M; Snel AN; Scheick JR; Scholten WJ; Carbaat-Ham J; Veldhuizen D; Hanekamp D; Oussoren-Brockhoff YJM; Kaspers GJL; Schuurhuis GJ; Sasser AK; Ossenkoppele G
    J Vis Exp; 2018 Mar; (133):. PubMed ID: 29553571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of morphocytochemical and immunophenotypic features of acute leukemia stem cells.
    Gluzman DF; Nadgornaya VA; Sklyarenko LM; Zavelevych MP; Koval SV; Poludnenko LY; Ivanovskaya TS
    Exp Oncol; 2008 Jun; 30(2):102-5. PubMed ID: 18566571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy.
    Behbehani GK; Samusik N; Bjornson ZB; Fantl WJ; Medeiros BC; Nolan GP
    Cancer Discov; 2015 Sep; 5(9):988-1003. PubMed ID: 26091827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.